Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.
There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.
The FDA has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
In one study, Ozempic users lost almost 6 percent of their body weight after three months. According to preliminary data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback